Utilities, Consumer...
Achillion Pharmaceuticals Inc. (ACHN: NASDAQ)
$9.47 -0.30 | -3.07%
02/09/12 - 04:00 PM ET
1.01M / 1.23M
Vol / Avg. Vol:9.81 / 9.77
Open / Prev. Close:9.40 - 10.00
Today's Range:3.81 - 12.95
52 Wk Range:36.15%
Performance YTD:TheStreet Rating:
Portfolios with ACHN
- Portfolio NameUser Type
- UserThe cash burners
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Hep C Stocks on Wall Str...
- Contributor10 Health-Care Stocks Outpe...
- ContributorHep C Drug Stocks in the Sp...
- UserStocks Under $5
- UserLegal Tender II
- UserTop Picks Under $5 for 2011...
- ContributorTop Stock Picks Under $5 fo...
- Userhpats Portfolio 1
Latest ACHN Headlines from TheStreet
- Biotech Stock Mailbag: Vical, Hep C Drugs 01.27.12 | 07:01 am
- BioLineRx: Tuesday's Hot Hep C Drug Stock 01.24.12 | 11:01 am
- Idenix Pharma Buyout Likely: Survey 01.20.12 | 03:01 pm
- Biotech Stock Mailbag: Celldex, Hep C Bubble, Al Mann Anger 01.20.12 | 05:01 am
- 4 Companies That Are Bleeding Cash 01.13.12 | 07:01 am
- More Biotech Lessons Learned From JPM 2012 01.13.12 | 06:01 am
- J.P. Morgan Biotech Confab Live Chat 01.09.12 | 07:01 pm
- Stocks to Watch: Inhibitex, Alcoa (Update 1) 01.09.12 | 08:01 am
- Stocks Drift Lower On First Day Of Earnings Season 01.09.12 | 07:01 am
- Hep C Takeover Speculation Rains Down on Idenix and Achillion 01.08.12 | 01:01 pm
Press Releases for ACHN
- Emerald Holds Annual Groundhog Day Investment Forum - Business Wire 02.06.12 | 08:02 am
Partner Headlines for ACHN
- 10 Biotech Stocks With 100% Upside In 2012: Part One - Seeking Alpha 02.09.12 | 10:02 am
- Company News for January 25, 2012 - Corporate Summary - Zacks 01.25.12 | 10:01 am
- Afternoon Movers; Negative Euro News - Benzinga 01.24.12 | 04:01 pm
- Benzinga's M&A Chatter for Friday January 20, 2012 - Benzinga 01.20.12 | 06:01 pm
- End-of-Day Market Summary for January 20, 2012 - Benzinga 01.20.12 | 04:01 pm
- Afternoon Movers; Markets Moved Sideways - Benzinga 01.20.12 | 04:01 pm
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- Analyzing 5 Biotech Stocks And Their Takeover Potential - Seeking Alpha 01.13.12 | 08:01 am
- Afternoon Movers; Markets Moved Higher - Benzinga 01.09.12 | 04:01 pm
- Forget Dendreon, Inhibitex is the New Biotech Success Story - Benzinga 01.09.12 | 01:01 pm





